Celebrating 20 years of induced pluripotent stem cell research
慶祝誘導性多功能幹細胞研究 20 週年
The year 2026 marks a major milestone: the 20th anniversary of the discovery of induced pluripotent stem cells (iPSCs).
2026年是一個重要的里程碑：誘導性多能幹細胞發現20週年。
In 2006, researchers Shinya Yamanaka and Kazutoshi Takahashi transformed science by reprogramming adult cells into a stem cell-like state.
2006年，研究人員山中伸彌和高橋和利透過將成體細胞重編程為類幹細胞狀態，徹底改變了科學界。
By using specific factors—Oct4, Sox2, Klf4, and c-Myc—they proved that cellular development could be a two-way street.
藉由使用特定的因子——Oct4、Sox2、Klf4和c-Myc——他們證明了細胞發育可以是雙向的。
This breakthrough offered an ethical alternative to embryonic stem cells and paved the way for personalized medicine.
這項突破為胚胎幹細胞提供了一種符合倫理的替代方案，並為個人化醫療鋪平了道路。
Scientists can now create disease-in-a-dish models, allowing for safer drug testing and deeper study into conditions like Parkinson’s disease.
科學家現在可以創造「疾病模型」(disease-in-a-dish)，從而進行更安全的藥物測試，並對帕金森氏症等疾病進行更深入的研究。
As we look forward, the integration of iPSC technology with gene editing and artificial intelligence promises to revolutionize medicine further.
展望未來，將iPSC技術與基因編輯和人工智慧相結合，預計將進一步徹底改變醫學。
Today, the global scientific community celebrates this anniversary as a testament to how far regenerative medicine has come and the incredible potential it holds for the next twenty years.
今天，全球科學界慶祝這一週年，這證明了再生醫學已取得長足的進步，並展現了其在未來二十年中不可思議的潛力。
